[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f6PnK6_Y8-8UJY7thEw-_l4j1G2ZLRj8ZC3YyVqDwRW0":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":30,"phaseBuckets":31,"rows":38},"Pacific University",[4],14,false,2,0,957,13,[13,15,17,20,22,24,26,28],{"name":14,"count":8},"Stress, Psychological",{"name":16,"count":8},"Aggression",{"name":18,"count":19},"Substance-Related Disorders",1,{"name":21,"count":19},"Diabetes (DM)",{"name":23,"count":19},"Dry Eye",{"name":25,"count":19},"Eye Strain",{"name":27,"count":19},"Visual Acuity",{"name":29,"count":19},"Color Perception",[],[32,33,34,35,36,37],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[39,66],{"intervention":40,"totalTrials":19,"cells":41},"Stulln Eyedrops",{"EARLY_PHASE1":42,"PHASE1":44,"PHASE2":46,"PHASE3":60,"PHASE4":62,"NA":64},{"trials":43,"activeCount":9},[],{"trials":45,"activeCount":9},[],{"trials":47,"activeCount":9},[48],{"nctId":49,"briefTitle":50,"status":51,"phases":52,"primaryCompletion":53,"completion":53,"start":54,"enrollment":9,"conditions":55,"interventions":58},"NCT05107791","Effects of Stulln and Accommodative Training","WITHDRAWN",[33,34],"2021-08-31","2021-03-15",[56,57],"Accommodation Disorder","Visual Fatigue",[40,59],"Thera Tears",{"trials":61,"activeCount":9},[],{"trials":63,"activeCount":9},[],{"trials":65,"activeCount":9},[],{"intervention":59,"totalTrials":19,"cells":67},{"EARLY_PHASE1":68,"PHASE1":70,"PHASE2":72,"PHASE3":78,"PHASE4":80,"NA":82},{"trials":69,"activeCount":9},[],{"trials":71,"activeCount":9},[],{"trials":73,"activeCount":9},[74],{"nctId":49,"briefTitle":50,"status":51,"phases":75,"primaryCompletion":53,"completion":53,"start":54,"enrollment":9,"conditions":76,"interventions":77},[33,34],[56,57],[40,59],{"trials":79,"activeCount":9},[],{"trials":81,"activeCount":9},[],{"trials":83,"activeCount":9},[]]